nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—ORM1—Vandetanib—thyroid cancer	0.196	0.314	CbGbCtD
Doxepin—HTR2B—Sorafenib—thyroid cancer	0.126	0.201	CbGbCtD
Doxepin—HTR2C—Sorafenib—thyroid cancer	0.0817	0.131	CbGbCtD
Doxepin—CYP2C19—Sorafenib—thyroid cancer	0.0322	0.0516	CbGbCtD
Doxepin—CYP1A2—Sorafenib—thyroid cancer	0.0297	0.0477	CbGbCtD
Doxepin—CYP2C9—Sorafenib—thyroid cancer	0.0268	0.0429	CbGbCtD
Doxepin—ABCB1—Sorafenib—thyroid cancer	0.026	0.0417	CbGbCtD
Doxepin—CYP3A4—Vandetanib—thyroid cancer	0.0258	0.0414	CbGbCtD
Doxepin—CYP2D6—Sorafenib—thyroid cancer	0.0245	0.0393	CbGbCtD
Doxepin—ABCB1—Doxorubicin—thyroid cancer	0.0158	0.0253	CbGbCtD
Doxepin—CYP3A4—Sorafenib—thyroid cancer	0.0156	0.025	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—thyroid cancer	0.0149	0.0238	CbGbCtD
Doxepin—CYP3A4—Doxorubicin—thyroid cancer	0.00945	0.0151	CbGbCtD
Doxepin—CHRM4—head—thyroid cancer	0.000723	0.047	CbGeAlD
Doxepin—CHRM1—saliva-secreting gland—thyroid cancer	0.000652	0.0424	CbGeAlD
Doxepin—HTR6—head—thyroid cancer	0.000647	0.042	CbGeAlD
Doxepin—HRH2—head—thyroid cancer	0.000591	0.0384	CbGeAlD
Doxepin—CHRM3—saliva-secreting gland—thyroid cancer	0.000583	0.0379	CbGeAlD
Doxepin—CHRM5—head—thyroid cancer	0.000565	0.0367	CbGeAlD
Doxepin—ADRA1B—head—thyroid cancer	0.000516	0.0336	CbGeAlD
Doxepin—ADRA1D—head—thyroid cancer	0.000505	0.0328	CbGeAlD
Doxepin—CHRM1—trachea—thyroid cancer	0.000503	0.0327	CbGeAlD
Doxepin—HTR2A—neck—thyroid cancer	0.000444	0.0289	CbGeAlD
Doxepin—HRH2—lymph node—thyroid cancer	0.000414	0.0269	CbGeAlD
Doxepin—Abdominal pain—Sorafenib—thyroid cancer	0.000408	0.00148	CcSEcCtD
Doxepin—Body temperature increased—Sorafenib—thyroid cancer	0.000408	0.00148	CcSEcCtD
Doxepin—Purpura—Epirubicin—thyroid cancer	0.000403	0.00146	CcSEcCtD
Doxepin—Vascular purpura—Doxorubicin—thyroid cancer	0.000401	0.00146	CcSEcCtD
Doxepin—Eczema—Doxorubicin—thyroid cancer	0.0004	0.00145	CcSEcCtD
Doxepin—Eye pain—Doxorubicin—thyroid cancer	0.000398	0.00145	CcSEcCtD
Doxepin—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000396	0.00144	CcSEcCtD
Doxepin—Lethargy—Epirubicin—thyroid cancer	0.000396	0.00144	CcSEcCtD
Doxepin—HTR2B—thyroid gland—thyroid cancer	0.000396	0.0257	CbGeAlD
Doxepin—ADRA2C—trachea—thyroid cancer	0.000394	0.0256	CbGeAlD
Doxepin—Pain in extremity—Epirubicin—thyroid cancer	0.000388	0.00141	CcSEcCtD
Doxepin—Diplopia—Epirubicin—thyroid cancer	0.000388	0.00141	CcSEcCtD
Doxepin—CHRM2—head—thyroid cancer	0.000388	0.0252	CbGeAlD
Doxepin—Hot flush—Doxorubicin—thyroid cancer	0.000384	0.00139	CcSEcCtD
Doxepin—Increased appetite—Doxorubicin—thyroid cancer	0.000382	0.00139	CcSEcCtD
Doxepin—Migraine—Epirubicin—thyroid cancer	0.000382	0.00139	CcSEcCtD
Doxepin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000381	0.00138	CcSEcCtD
Doxepin—Hypersensitivity—Sorafenib—thyroid cancer	0.00038	0.00138	CcSEcCtD
Doxepin—HTR2C—head—thyroid cancer	0.000374	0.0243	CbGeAlD
Doxepin—Purpura—Doxorubicin—thyroid cancer	0.000373	0.00135	CcSEcCtD
Doxepin—Asthenia—Sorafenib—thyroid cancer	0.00037	0.00135	CcSEcCtD
Doxepin—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000366	0.00133	CcSEcCtD
Doxepin—Lethargy—Doxorubicin—thyroid cancer	0.000366	0.00133	CcSEcCtD
Doxepin—Pruritus—Sorafenib—thyroid cancer	0.000365	0.00133	CcSEcCtD
Doxepin—Ataxia—Epirubicin—thyroid cancer	0.000365	0.00133	CcSEcCtD
Doxepin—Diplopia—Doxorubicin—thyroid cancer	0.000359	0.0013	CcSEcCtD
Doxepin—Pain in extremity—Doxorubicin—thyroid cancer	0.000359	0.0013	CcSEcCtD
Doxepin—CHRM3—thyroid gland—thyroid cancer	0.000356	0.0231	CbGeAlD
Doxepin—SLC6A4—head—thyroid cancer	0.000354	0.023	CbGeAlD
Doxepin—Migraine—Doxorubicin—thyroid cancer	0.000353	0.00128	CcSEcCtD
Doxepin—Hypokalaemia—Epirubicin—thyroid cancer	0.000353	0.00128	CcSEcCtD
Doxepin—Diarrhoea—Sorafenib—thyroid cancer	0.000353	0.00128	CcSEcCtD
Doxepin—CHRM1—head—thyroid cancer	0.000353	0.0229	CbGeAlD
Doxepin—HTR2B—head—thyroid cancer	0.000351	0.0228	CbGeAlD
Doxepin—Breast disorder—Epirubicin—thyroid cancer	0.000351	0.00127	CcSEcCtD
Doxepin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000347	0.00126	CcSEcCtD
Doxepin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000342	0.00124	CcSEcCtD
Doxepin—Dizziness—Sorafenib—thyroid cancer	0.000341	0.00124	CcSEcCtD
Doxepin—Ataxia—Doxorubicin—thyroid cancer	0.000338	0.00123	CcSEcCtD
Doxepin—Asthma—Epirubicin—thyroid cancer	0.000335	0.00122	CcSEcCtD
Doxepin—Influenza—Epirubicin—thyroid cancer	0.000335	0.00122	CcSEcCtD
Doxepin—Eosinophilia—Epirubicin—thyroid cancer	0.000332	0.00121	CcSEcCtD
Doxepin—Vomiting—Sorafenib—thyroid cancer	0.000328	0.00119	CcSEcCtD
Doxepin—Hypokalaemia—Doxorubicin—thyroid cancer	0.000327	0.00119	CcSEcCtD
Doxepin—Rash—Sorafenib—thyroid cancer	0.000325	0.00118	CcSEcCtD
Doxepin—Dermatitis—Sorafenib—thyroid cancer	0.000325	0.00118	CcSEcCtD
Doxepin—Breast disorder—Doxorubicin—thyroid cancer	0.000324	0.00118	CcSEcCtD
Doxepin—Headache—Sorafenib—thyroid cancer	0.000323	0.00117	CcSEcCtD
Doxepin—Bronchitis—Epirubicin—thyroid cancer	0.000323	0.00117	CcSEcCtD
Doxepin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000321	0.00117	CcSEcCtD
Doxepin—HRH1—trachea—thyroid cancer	0.00032	0.0208	CbGeAlD
Doxepin—Pancytopenia—Epirubicin—thyroid cancer	0.000319	0.00116	CcSEcCtD
Doxepin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000317	0.00115	CcSEcCtD
Doxepin—CHRM3—head—thyroid cancer	0.000316	0.0205	CbGeAlD
Doxepin—HTR1A—head—thyroid cancer	0.000315	0.0205	CbGeAlD
Doxepin—ADRA2A—trachea—thyroid cancer	0.000314	0.0204	CbGeAlD
Doxepin—Dysuria—Epirubicin—thyroid cancer	0.000314	0.00114	CcSEcCtD
Doxepin—SLC6A2—head—thyroid cancer	0.000312	0.0203	CbGeAlD
Doxepin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000312	0.00113	CcSEcCtD
Doxepin—Influenza—Doxorubicin—thyroid cancer	0.00031	0.00113	CcSEcCtD
Doxepin—Asthma—Doxorubicin—thyroid cancer	0.00031	0.00113	CcSEcCtD
Doxepin—Pollakiuria—Epirubicin—thyroid cancer	0.00031	0.00113	CcSEcCtD
Doxepin—Eosinophilia—Doxorubicin—thyroid cancer	0.000307	0.00112	CcSEcCtD
Doxepin—Nausea—Sorafenib—thyroid cancer	0.000307	0.00111	CcSEcCtD
Doxepin—Weight increased—Epirubicin—thyroid cancer	0.000305	0.00111	CcSEcCtD
Doxepin—Pneumonia—Epirubicin—thyroid cancer	0.000301	0.00109	CcSEcCtD
Doxepin—Infestation NOS—Epirubicin—thyroid cancer	0.000299	0.00109	CcSEcCtD
Doxepin—Drowsiness—Epirubicin—thyroid cancer	0.000299	0.00109	CcSEcCtD
Doxepin—Infestation—Epirubicin—thyroid cancer	0.000299	0.00109	CcSEcCtD
Doxepin—Bronchitis—Doxorubicin—thyroid cancer	0.000298	0.00108	CcSEcCtD
Doxepin—Pancytopenia—Doxorubicin—thyroid cancer	0.000295	0.00107	CcSEcCtD
Doxepin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000293	0.00107	CcSEcCtD
Doxepin—Stomatitis—Epirubicin—thyroid cancer	0.000292	0.00106	CcSEcCtD
Doxepin—Jaundice—Epirubicin—thyroid cancer	0.000292	0.00106	CcSEcCtD
Doxepin—ORM1—lymph node—thyroid cancer	0.000291	0.0189	CbGeAlD
Doxepin—Urinary tract infection—Epirubicin—thyroid cancer	0.000291	0.00106	CcSEcCtD
Doxepin—Dysuria—Doxorubicin—thyroid cancer	0.00029	0.00105	CcSEcCtD
Doxepin—ADRA1A—head—thyroid cancer	0.00029	0.0189	CbGeAlD
Doxepin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000288	0.00105	CcSEcCtD
Doxepin—Sweating—Epirubicin—thyroid cancer	0.000287	0.00104	CcSEcCtD
Doxepin—Pollakiuria—Doxorubicin—thyroid cancer	0.000287	0.00104	CcSEcCtD
Doxepin—DRD2—head—thyroid cancer	0.000284	0.0185	CbGeAlD
Doxepin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000283	0.00103	CcSEcCtD
Doxepin—Weight increased—Doxorubicin—thyroid cancer	0.000282	0.00103	CcSEcCtD
Doxepin—Sinusitis—Epirubicin—thyroid cancer	0.000281	0.00102	CcSEcCtD
Doxepin—KCNH2—head—thyroid cancer	0.00028	0.0182	CbGeAlD
Doxepin—Agranulocytosis—Epirubicin—thyroid cancer	0.000279	0.00101	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—thyroid cancer	0.000278	0.00101	CcSEcCtD
Doxepin—Infestation—Doxorubicin—thyroid cancer	0.000277	0.00101	CcSEcCtD
Doxepin—Infestation NOS—Doxorubicin—thyroid cancer	0.000277	0.00101	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—thyroid cancer	0.000277	0.00101	CcSEcCtD
Doxepin—ADRA2C—head—thyroid cancer	0.000276	0.018	CbGeAlD
Doxepin—Bradycardia—Epirubicin—thyroid cancer	0.000273	0.000993	CcSEcCtD
Doxepin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000271	0.000986	CcSEcCtD
Doxepin—CYP1A2—thyroid gland—thyroid cancer	0.00027	0.0176	CbGeAlD
Doxepin—Jaundice—Doxorubicin—thyroid cancer	0.00027	0.00098	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—thyroid cancer	0.00027	0.00098	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000269	0.000977	CcSEcCtD
Doxepin—Hepatitis—Epirubicin—thyroid cancer	0.000268	0.000975	CcSEcCtD
Doxepin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000267	0.000971	CcSEcCtD
Doxepin—HTR2A—trachea—thyroid cancer	0.000267	0.0174	CbGeAlD
Doxepin—Pharyngitis—Epirubicin—thyroid cancer	0.000266	0.000968	CcSEcCtD
Doxepin—Sweating—Doxorubicin—thyroid cancer	0.000265	0.000964	CcSEcCtD
Doxepin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000265	0.000963	CcSEcCtD
Doxepin—Oedema peripheral—Epirubicin—thyroid cancer	0.000264	0.000961	CcSEcCtD
Doxepin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000264	0.000959	CcSEcCtD
Doxepin—Urethral disorder—Epirubicin—thyroid cancer	0.000263	0.000956	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000262	0.000951	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—thyroid cancer	0.00026	0.000943	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—thyroid cancer	0.000258	0.000938	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—thyroid cancer	0.000253	0.000919	CcSEcCtD
Doxepin—Eye disorder—Epirubicin—thyroid cancer	0.000251	0.000912	CcSEcCtD
Doxepin—Tinnitus—Epirubicin—thyroid cancer	0.00025	0.000909	CcSEcCtD
Doxepin—Cardiac disorder—Epirubicin—thyroid cancer	0.000249	0.000905	CcSEcCtD
Doxepin—Flushing—Epirubicin—thyroid cancer	0.000249	0.000905	CcSEcCtD
Doxepin—ADRA2A—thyroid gland—thyroid cancer	0.000249	0.0162	CbGeAlD
Doxepin—Hepatitis—Doxorubicin—thyroid cancer	0.000248	0.000903	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000247	0.000898	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—thyroid cancer	0.000247	0.000896	CcSEcCtD
Doxepin—HTR2B—lymph node—thyroid cancer	0.000246	0.016	CbGeAlD
Doxepin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000245	0.000891	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000245	0.000889	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000244	0.000887	CcSEcCtD
Doxepin—Angiopathy—Epirubicin—thyroid cancer	0.000244	0.000885	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—thyroid cancer	0.000244	0.000885	CcSEcCtD
Doxepin—Immune system disorder—Epirubicin—thyroid cancer	0.000243	0.000881	CcSEcCtD
Doxepin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000242	0.000879	CcSEcCtD
Doxepin—Chills—Epirubicin—thyroid cancer	0.000241	0.000875	CcSEcCtD
Doxepin—Arrhythmia—Epirubicin—thyroid cancer	0.00024	0.000871	CcSEcCtD
Doxepin—Alopecia—Epirubicin—thyroid cancer	0.000237	0.000862	CcSEcCtD
Doxepin—Mental disorder—Epirubicin—thyroid cancer	0.000235	0.000855	CcSEcCtD
Doxepin—Malnutrition—Epirubicin—thyroid cancer	0.000234	0.000849	CcSEcCtD
Doxepin—Erythema—Epirubicin—thyroid cancer	0.000234	0.000849	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—thyroid cancer	0.000232	0.000843	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—thyroid cancer	0.000232	0.000842	CcSEcCtD
Doxepin—Flushing—Doxorubicin—thyroid cancer	0.000231	0.000838	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000231	0.000838	CcSEcCtD
Doxepin—Flatulence—Epirubicin—thyroid cancer	0.00023	0.000837	CcSEcCtD
Doxepin—Tension—Epirubicin—thyroid cancer	0.000229	0.000833	CcSEcCtD
Doxepin—Dysgeusia—Epirubicin—thyroid cancer	0.000229	0.000832	CcSEcCtD
Doxepin—Nervousness—Epirubicin—thyroid cancer	0.000227	0.000825	CcSEcCtD
Doxepin—Back pain—Epirubicin—thyroid cancer	0.000226	0.000821	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—thyroid cancer	0.000225	0.000819	CcSEcCtD
Doxepin—Muscle spasms—Epirubicin—thyroid cancer	0.000225	0.000816	CcSEcCtD
Doxepin—HRH1—head—thyroid cancer	0.000224	0.0146	CbGeAlD
Doxepin—Immune system disorder—Doxorubicin—thyroid cancer	0.000224	0.000815	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000224	0.000813	CcSEcCtD
Doxepin—Chills—Doxorubicin—thyroid cancer	0.000223	0.00081	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—thyroid cancer	0.000222	0.000806	CcSEcCtD
Doxepin—ADRA2A—head—thyroid cancer	0.00022	0.0143	CbGeAlD
Doxepin—Vision blurred—Epirubicin—thyroid cancer	0.00022	0.0008	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—thyroid cancer	0.00022	0.000798	CcSEcCtD
Doxepin—SLC6A2—lymph node—thyroid cancer	0.000218	0.0142	CbGeAlD
Doxepin—Mental disorder—Doxorubicin—thyroid cancer	0.000218	0.000791	CcSEcCtD
Doxepin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000217	0.000788	CcSEcCtD
Doxepin—Erythema—Doxorubicin—thyroid cancer	0.000216	0.000786	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—thyroid cancer	0.000216	0.000786	CcSEcCtD
Doxepin—Anaemia—Epirubicin—thyroid cancer	0.000216	0.000785	CcSEcCtD
Doxepin—Agitation—Epirubicin—thyroid cancer	0.000215	0.00078	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—thyroid cancer	0.000213	0.000774	CcSEcCtD
Doxepin—Tension—Doxorubicin—thyroid cancer	0.000212	0.000771	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—thyroid cancer	0.000212	0.000769	CcSEcCtD
Doxepin—Malaise—Epirubicin—thyroid cancer	0.000211	0.000766	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—thyroid cancer	0.00021	0.000763	CcSEcCtD
Doxepin—Vertigo—Epirubicin—thyroid cancer	0.00021	0.000763	CcSEcCtD
Doxepin—Syncope—Epirubicin—thyroid cancer	0.00021	0.000761	CcSEcCtD
Doxepin—Leukopenia—Epirubicin—thyroid cancer	0.000209	0.00076	CcSEcCtD
Doxepin—Back pain—Doxorubicin—thyroid cancer	0.000209	0.00076	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—thyroid cancer	0.000208	0.000755	CcSEcCtD
Doxepin—Palpitations—Epirubicin—thyroid cancer	0.000207	0.00075	CcSEcCtD
Doxepin—Loss of consciousness—Epirubicin—thyroid cancer	0.000205	0.000746	CcSEcCtD
Doxepin—Cough—Epirubicin—thyroid cancer	0.000204	0.000741	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—thyroid cancer	0.000204	0.00074	CcSEcCtD
Doxepin—Convulsion—Epirubicin—thyroid cancer	0.000202	0.000736	CcSEcCtD
Doxepin—Hypertension—Epirubicin—thyroid cancer	0.000202	0.000733	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000201	0.000729	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—thyroid cancer	0.0002	0.000726	CcSEcCtD
Doxepin—Arthralgia—Epirubicin—thyroid cancer	0.000199	0.000723	CcSEcCtD
Doxepin—Myalgia—Epirubicin—thyroid cancer	0.000199	0.000723	CcSEcCtD
Doxepin—Chest pain—Epirubicin—thyroid cancer	0.000199	0.000723	CcSEcCtD
Doxepin—Agitation—Doxorubicin—thyroid cancer	0.000199	0.000722	CcSEcCtD
Doxepin—Anxiety—Epirubicin—thyroid cancer	0.000198	0.00072	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000198	0.000718	CcSEcCtD
Doxepin—Discomfort—Epirubicin—thyroid cancer	0.000197	0.000714	CcSEcCtD
Doxepin—KCNH2—lymph node—thyroid cancer	0.000196	0.0127	CbGeAlD
Doxepin—Malaise—Doxorubicin—thyroid cancer	0.000195	0.000709	CcSEcCtD
Doxepin—Dry mouth—Epirubicin—thyroid cancer	0.000195	0.000707	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—thyroid cancer	0.000194	0.000706	CcSEcCtD
Doxepin—Syncope—Doxorubicin—thyroid cancer	0.000194	0.000705	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—thyroid cancer	0.000194	0.000703	CcSEcCtD
Doxepin—ADRA2C—lymph node—thyroid cancer	0.000193	0.0126	CbGeAlD
Doxepin—Confusional state—Epirubicin—thyroid cancer	0.000192	0.000699	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—thyroid cancer	0.000191	0.000694	CcSEcCtD
Doxepin—Oedema—Epirubicin—thyroid cancer	0.000191	0.000693	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—thyroid cancer	0.00019	0.000691	CcSEcCtD
Doxepin—Infection—Epirubicin—thyroid cancer	0.000189	0.000688	CcSEcCtD
Doxepin—Cough—Doxorubicin—thyroid cancer	0.000189	0.000686	CcSEcCtD
Doxepin—Shock—Epirubicin—thyroid cancer	0.000188	0.000682	CcSEcCtD
Doxepin—HTR2A—head—thyroid cancer	0.000187	0.0122	CbGeAlD
Doxepin—Convulsion—Doxorubicin—thyroid cancer	0.000187	0.000681	CcSEcCtD
Doxepin—Nervous system disorder—Epirubicin—thyroid cancer	0.000187	0.00068	CcSEcCtD
Doxepin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000187	0.000679	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—thyroid cancer	0.000187	0.000678	CcSEcCtD
Doxepin—Tachycardia—Epirubicin—thyroid cancer	0.000186	0.000676	CcSEcCtD
Doxepin—Skin disorder—Epirubicin—thyroid cancer	0.000185	0.000673	CcSEcCtD
Doxepin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000184	0.00067	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—thyroid cancer	0.000184	0.000669	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—thyroid cancer	0.000184	0.000669	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—thyroid cancer	0.000184	0.000669	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—thyroid cancer	0.000183	0.000667	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000183	0.000664	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—thyroid cancer	0.000182	0.000661	CcSEcCtD
Doxepin—Anorexia—Epirubicin—thyroid cancer	0.000182	0.000661	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—thyroid cancer	0.00018	0.000654	CcSEcCtD
Doxepin—Hypotension—Epirubicin—thyroid cancer	0.000178	0.000648	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—thyroid cancer	0.000178	0.000647	CcSEcCtD
Doxepin—Oedema—Doxorubicin—thyroid cancer	0.000176	0.000641	CcSEcCtD
Doxepin—Infection—Doxorubicin—thyroid cancer	0.000175	0.000637	CcSEcCtD
Doxepin—ABCB1—trachea—thyroid cancer	0.000175	0.0114	CbGeAlD
Doxepin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000174	0.000631	CcSEcCtD
Doxepin—Shock—Doxorubicin—thyroid cancer	0.000174	0.000631	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000173	0.000629	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000173	0.000628	CcSEcCtD
Doxepin—Insomnia—Epirubicin—thyroid cancer	0.000173	0.000627	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—thyroid cancer	0.000172	0.000626	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—thyroid cancer	0.000171	0.000623	CcSEcCtD
Doxepin—Paraesthesia—Epirubicin—thyroid cancer	0.000171	0.000622	CcSEcCtD
Doxepin—CYP2D6—head—thyroid cancer	0.000171	0.0111	CbGeAlD
Doxepin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000171	0.00062	CcSEcCtD
Doxepin—Dyspnoea—Epirubicin—thyroid cancer	0.00017	0.000618	CcSEcCtD
Doxepin—Somnolence—Epirubicin—thyroid cancer	0.00017	0.000616	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—thyroid cancer	0.000168	0.000611	CcSEcCtD
Doxepin—Dyspepsia—Epirubicin—thyroid cancer	0.000168	0.00061	CcSEcCtD
Doxepin—Decreased appetite—Epirubicin—thyroid cancer	0.000166	0.000602	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—thyroid cancer	0.000165	0.000599	CcSEcCtD
Doxepin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000165	0.000598	CcSEcCtD
Doxepin—Fatigue—Epirubicin—thyroid cancer	0.000164	0.000597	CcSEcCtD
Doxepin—Constipation—Epirubicin—thyroid cancer	0.000163	0.000593	CcSEcCtD
Doxepin—Pain—Epirubicin—thyroid cancer	0.000163	0.000593	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000161	0.000584	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—thyroid cancer	0.00016	0.00058	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—thyroid cancer	0.000158	0.000576	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—thyroid cancer	0.000157	0.000572	CcSEcCtD
Doxepin—Feeling abnormal—Epirubicin—thyroid cancer	0.000157	0.000571	CcSEcCtD
Doxepin—HRH1—lymph node—thyroid cancer	0.000157	0.0102	CbGeAlD
Doxepin—Somnolence—Doxorubicin—thyroid cancer	0.000157	0.00057	CcSEcCtD
Doxepin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000156	0.000567	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—thyroid cancer	0.000155	0.000564	CcSEcCtD
Doxepin—ADRA2A—lymph node—thyroid cancer	0.000154	0.01	CbGeAlD
Doxepin—Decreased appetite—Doxorubicin—thyroid cancer	0.000153	0.000557	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000152	0.000554	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—thyroid cancer	0.000152	0.000553	CcSEcCtD
Doxepin—Urticaria—Epirubicin—thyroid cancer	0.000152	0.000551	CcSEcCtD
Doxepin—Pain—Doxorubicin—thyroid cancer	0.000151	0.000548	CcSEcCtD
Doxepin—Constipation—Doxorubicin—thyroid cancer	0.000151	0.000548	CcSEcCtD
Doxepin—Abdominal pain—Epirubicin—thyroid cancer	0.000151	0.000548	CcSEcCtD
Doxepin—Body temperature increased—Epirubicin—thyroid cancer	0.000151	0.000548	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000145	0.000528	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000144	0.000524	CcSEcCtD
Doxepin—Hypersensitivity—Epirubicin—thyroid cancer	0.000141	0.000511	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—thyroid cancer	0.00014	0.000509	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—thyroid cancer	0.00014	0.000507	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—thyroid cancer	0.00014	0.000507	CcSEcCtD
Doxepin—ABCB1—thyroid gland—thyroid cancer	0.000138	0.009	CbGeAlD
Doxepin—Asthenia—Epirubicin—thyroid cancer	0.000137	0.000497	CcSEcCtD
Doxepin—Pruritus—Epirubicin—thyroid cancer	0.000135	0.00049	CcSEcCtD
Doxepin—Diarrhoea—Epirubicin—thyroid cancer	0.000131	0.000474	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—thyroid cancer	0.00013	0.000472	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—thyroid cancer	0.000127	0.00046	CcSEcCtD
Doxepin—Dizziness—Epirubicin—thyroid cancer	0.000126	0.000458	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—thyroid cancer	0.000125	0.000454	CcSEcCtD
Doxepin—ABCB1—head—thyroid cancer	0.000123	0.00799	CbGeAlD
Doxepin—Vomiting—Epirubicin—thyroid cancer	0.000121	0.000441	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—thyroid cancer	0.000121	0.000439	CcSEcCtD
Doxepin—Rash—Epirubicin—thyroid cancer	0.00012	0.000437	CcSEcCtD
Doxepin—Dermatitis—Epirubicin—thyroid cancer	0.00012	0.000437	CcSEcCtD
Doxepin—Headache—Epirubicin—thyroid cancer	0.000119	0.000434	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—thyroid cancer	0.000117	0.000424	CcSEcCtD
Doxepin—Nausea—Epirubicin—thyroid cancer	0.000113	0.000412	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—thyroid cancer	0.000112	0.000408	CcSEcCtD
Doxepin—Rash—Doxorubicin—thyroid cancer	0.000111	0.000404	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—thyroid cancer	0.000111	0.000404	CcSEcCtD
Doxepin—Headache—Doxorubicin—thyroid cancer	0.000111	0.000402	CcSEcCtD
Doxepin—Nausea—Doxorubicin—thyroid cancer	0.000105	0.000381	CcSEcCtD
Doxepin—ABCB1—lymph node—thyroid cancer	8.6e-05	0.00559	CbGeAlD
Doxepin—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.16e-05	0.000136	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—KRAS—thyroid cancer	1.16e-05	0.000135	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	1.16e-05	0.000135	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PTEN—thyroid cancer	1.15e-05	0.000135	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—HRAS—thyroid cancer	1.15e-05	0.000135	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.15e-05	0.000135	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	1.15e-05	0.000135	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.14e-05	0.000133	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.14e-05	0.000133	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PTGS2—thyroid cancer	1.13e-05	0.000133	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.13e-05	0.000132	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.13e-05	0.000132	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CCND1—thyroid cancer	1.13e-05	0.000132	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—AKT1—thyroid cancer	1.13e-05	0.000132	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—AKT1—thyroid cancer	1.12e-05	0.000131	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—AKT1—thyroid cancer	1.12e-05	0.000131	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.11e-05	0.00013	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.11e-05	0.00013	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.11e-05	0.00013	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	1.11e-05	0.00013	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—NRAS—thyroid cancer	1.11e-05	0.000129	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.1e-05	0.000129	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	1.09e-05	0.000128	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.09e-05	0.000128	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.09e-05	0.000128	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PTEN—thyroid cancer	1.09e-05	0.000127	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	1.08e-05	0.000127	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CCND1—thyroid cancer	1.08e-05	0.000126	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	1.07e-05	0.000126	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.06e-05	0.000125	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—AKT1—thyroid cancer	1.06e-05	0.000124	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	1.06e-05	0.000124	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PTEN—thyroid cancer	1.05e-05	0.000123	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	1.05e-05	0.000123	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.05e-05	0.000123	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.05e-05	0.000122	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PTEN—thyroid cancer	1.04e-05	0.000122	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—BRAF—thyroid cancer	1.04e-05	0.000122	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—BRAF—thyroid cancer	1.04e-05	0.000121	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—NRAS—thyroid cancer	1.03e-05	0.00012	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—BRAF—thyroid cancer	1.03e-05	0.00012	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	1.03e-05	0.00012	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—thyroid cancer	1.03e-05	0.00012	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.03e-05	0.00012	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—RXRA—thyroid cancer	1.02e-05	0.00012	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—AKT1—thyroid cancer	1.02e-05	0.000119	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	1.02e-05	0.000119	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.01e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTGS2—thyroid cancer	1e-05	0.000117	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.95e-06	0.000116	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PTEN—thyroid cancer	9.89e-06	0.000116	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—HRAS—thyroid cancer	9.82e-06	0.000115	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	9.8e-06	0.000115	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	9.78e-06	0.000114	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—KRAS—thyroid cancer	9.75e-06	0.000114	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—NRAS—thyroid cancer	9.71e-06	0.000114	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	9.59e-06	0.000112	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—KRAS—thyroid cancer	9.57e-06	0.000112	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	9.56e-06	0.000112	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	9.54e-06	0.000112	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	9.53e-06	0.000111	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	9.51e-06	0.000111	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	9.51e-06	0.000111	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	9.44e-06	0.00011	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	9.42e-06	0.00011	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	9.4e-06	0.00011	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NRAS—thyroid cancer	9.4e-06	0.00011	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	9.39e-06	0.00011	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	9.39e-06	0.00011	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NRAS—thyroid cancer	9.3e-06	0.000109	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTGS2—thyroid cancer	9.21e-06	0.000108	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	9.18e-06	0.000107	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	9.17e-06	0.000107	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	9.13e-06	0.000107	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	9.13e-06	0.000107	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	8.99e-06	0.000105	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	8.88e-06	0.000104	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—KRAS—thyroid cancer	8.86e-06	0.000104	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCND1—thyroid cancer	8.85e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	8.85e-06	0.000103	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCND1—thyroid cancer	8.81e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTEN—thyroid cancer	8.75e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	8.75e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	8.74e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	8.73e-06	0.000102	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—thyroid cancer	8.67e-06	0.000101	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	8.63e-06	0.000101	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	8.57e-06	0.0001	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PTEN—thyroid cancer	8.54e-06	9.99e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PTEN—thyroid cancer	8.5e-06	9.94e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	8.43e-06	9.86e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—KRAS—thyroid cancer	8.36e-06	9.78e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	8.34e-06	9.75e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—thyroid cancer	8.29e-06	9.7e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	8.29e-06	9.7e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—HRAS—thyroid cancer	8.29e-06	9.69e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	8.27e-06	9.67e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	8.16e-06	9.54e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—HRAS—thyroid cancer	8.14e-06	9.52e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	8.14e-06	9.51e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	8.11e-06	9.49e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—thyroid cancer	8.09e-06	9.47e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—KRAS—thyroid cancer	8.09e-06	9.46e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	8.09e-06	9.46e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	8.07e-06	9.43e-05	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	8.06e-06	9.42e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTEN—thyroid cancer	8.03e-06	9.39e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	8.01e-06	9.36e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—KRAS—thyroid cancer	8.01e-06	9.36e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	7.99e-06	9.34e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	7.94e-06	9.28e-05	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	7.93e-06	9.27e-05	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	7.91e-06	9.25e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—RXRA—thyroid cancer	7.9e-06	9.24e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	7.9e-06	9.23e-05	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	7.89e-06	9.22e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—thyroid cancer	7.88e-06	9.21e-05	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	7.86e-06	9.19e-05	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	7.79e-06	9.1e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCND1—thyroid cancer	7.77e-06	9.09e-05	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	7.76e-06	9.08e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCND1—thyroid cancer	7.65e-06	8.94e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCND1—thyroid cancer	7.63e-06	8.92e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—thyroid cancer	7.63e-06	8.92e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NRAS—thyroid cancer	7.62e-06	8.91e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCND1—thyroid cancer	7.61e-06	8.89e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NRAS—thyroid cancer	7.58e-06	8.87e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCND1—thyroid cancer	7.58e-06	8.87e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—thyroid cancer	7.56e-06	8.84e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HRAS—thyroid cancer	7.53e-06	8.81e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	7.53e-06	8.8e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—thyroid cancer	7.51e-06	8.78e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PTEN—thyroid cancer	7.5e-06	8.77e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	7.49e-06	8.76e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—thyroid cancer	7.43e-06	8.69e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	7.42e-06	8.68e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PTEN—thyroid cancer	7.38e-06	8.63e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	7.38e-06	8.63e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PTEN—thyroid cancer	7.37e-06	8.61e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PTEN—thyroid cancer	7.34e-06	8.59e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—thyroid cancer	7.32e-06	8.56e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PTEN—thyroid cancer	7.32e-06	8.56e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	7.26e-06	8.49e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PTEN—thyroid cancer	7.25e-06	8.47e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	7.23e-06	8.45e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	7.21e-06	8.44e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	7.2e-06	8.42e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—thyroid cancer	7.19e-06	8.41e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—thyroid cancer	7.19e-06	8.4e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	7.16e-06	8.38e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	7.14e-06	8.35e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—thyroid cancer	7.12e-06	8.32e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—thyroid cancer	7.11e-06	8.31e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	7.07e-06	8.27e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	7.05e-06	8.25e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	6.96e-06	8.14e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—thyroid cancer	6.88e-06	8.04e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—thyroid cancer	6.81e-06	7.96e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	6.8e-06	7.95e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	6.72e-06	7.85e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NRAS—thyroid cancer	6.69e-06	7.83e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—thyroid cancer	6.69e-06	7.82e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—thyroid cancer	6.65e-06	7.78e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NRAS—thyroid cancer	6.59e-06	7.7e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NRAS—thyroid cancer	6.57e-06	7.68e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—thyroid cancer	6.56e-06	7.67e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	6.55e-06	7.66e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NRAS—thyroid cancer	6.55e-06	7.66e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NRAS—thyroid cancer	6.53e-06	7.64e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—thyroid cancer	6.53e-06	7.63e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—thyroid cancer	6.52e-06	7.63e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NRAS—thyroid cancer	6.47e-06	7.56e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—thyroid cancer	6.46e-06	7.56e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	6.45e-06	7.54e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	6.4e-06	7.48e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—thyroid cancer	6.37e-06	7.45e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	6.35e-06	7.42e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—thyroid cancer	6.27e-06	7.34e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	6.25e-06	7.31e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—thyroid cancer	6.07e-06	7.1e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—thyroid cancer	6.04e-06	7.06e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—thyroid cancer	6.01e-06	7.03e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—thyroid cancer	6e-06	7.02e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	5.99e-06	7.01e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.95e-06	6.96e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—thyroid cancer	5.83e-06	6.82e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—thyroid cancer	5.8e-06	6.78e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	5.78e-06	6.76e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—thyroid cancer	5.76e-06	6.74e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—thyroid cancer	5.7e-06	6.66e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTEN—thyroid cancer	5.69e-06	6.65e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—thyroid cancer	5.67e-06	6.63e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—thyroid cancer	5.66e-06	6.61e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	5.65e-06	6.61e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—thyroid cancer	5.64e-06	6.6e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—thyroid cancer	5.64e-06	6.59e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—thyroid cancer	5.62e-06	6.57e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—thyroid cancer	5.58e-06	6.52e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—thyroid cancer	5.56e-06	6.51e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTEN—thyroid cancer	5.55e-06	6.49e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—thyroid cancer	5.55e-06	6.49e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	5.55e-06	6.49e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—thyroid cancer	5.55e-06	6.49e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	5.4e-06	6.31e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	5.31e-06	6.21e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTEN—thyroid cancer	5.23e-06	6.12e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTEN—thyroid cancer	5.19e-06	6.07e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	5.16e-06	6.03e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—thyroid cancer	5.12e-06	5.99e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	5.1e-06	5.96e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.08e-06	5.94e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—thyroid cancer	5.04e-06	5.9e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—thyroid cancer	5.04e-06	5.89e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—thyroid cancer	5.03e-06	5.88e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—thyroid cancer	5.01e-06	5.86e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—thyroid cancer	4.99e-06	5.84e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—thyroid cancer	4.99e-06	5.83e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—thyroid cancer	4.95e-06	5.78e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—thyroid cancer	4.93e-06	5.77e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—thyroid cancer	4.92e-06	5.76e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—thyroid cancer	4.9e-06	5.73e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—thyroid cancer	4.9e-06	5.73e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—thyroid cancer	4.82e-06	5.63e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—thyroid cancer	4.81e-06	5.62e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—thyroid cancer	4.79e-06	5.6e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—thyroid cancer	4.78e-06	5.59e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	4.76e-06	5.57e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—thyroid cancer	4.73e-06	5.53e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	4.72e-06	5.52e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	4.69e-06	5.48e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—thyroid cancer	4.63e-06	5.41e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—thyroid cancer	4.58e-06	5.36e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTEN—thyroid cancer	4.43e-06	5.18e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	4.38e-06	5.13e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—thyroid cancer	4.32e-06	5.06e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—thyroid cancer	4.25e-06	4.97e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—thyroid cancer	4.24e-06	4.96e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—thyroid cancer	4.23e-06	4.95e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—thyroid cancer	4.22e-06	4.93e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—thyroid cancer	4.18e-06	4.88e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	4.17e-06	4.87e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.92e-06	4.59e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	3.87e-06	4.53e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTEN—thyroid cancer	3.42e-06	4e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—thyroid cancer	3.28e-06	3.83e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—thyroid cancer	3.2e-06	3.74e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—thyroid cancer	3.02e-06	3.53e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—thyroid cancer	2.99e-06	3.5e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—thyroid cancer	2.55e-06	2.99e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—thyroid cancer	1.97e-06	2.31e-05	CbGpPWpGaD
